{"version":"1.0","provider_name":"Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB","provider_url":"https:\/\/www.izb-online.de\/en\/","title":"Pieris develops a new generation of medicine","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"b8vVQn7oXq\"><a href=\"https:\/\/www.izb-online.de\/en\/pieris-develops-a-new-generation-of-medicine\/\">Pieris develops a new generation of medicine<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.izb-online.de\/en\/pieris-develops-a-new-generation-of-medicine\/embed\/#?secret=b8vVQn7oXq\" width=\"600\" height=\"338\" title=\"&#8220;Pieris develops a new generation of medicine&#8221; &#8212; Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB\" data-secret=\"b8vVQn7oXq\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.izb-online.de\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","thumbnail_url":"https:\/\/www.izb-online.de\/wp-content\/uploads\/2017\/03\/zellen.jpg","thumbnail_width":400,"thumbnail_height":341,"description":"Pieris Pharmaceuticals, located in Boston, USA and at the IZB Weihenstephan near Munich, has already signed two \u00adsignificant alliances in 2017. In January, an immuno-\u00adoncology focused deal with French pharmaceutical group Servier led to a cash injection north of 30 million US Dollars. A subsequent alliance with Anglo\u2013Swedish pharma company AstraZeneca resulted in an upfront payment of another 45 million Euro with potential subsequent payments well in the billions.\u00a0 The biotechnology firm, which was spun out of the TU M\u00fcnchen in 2001 with Prof. Arne Skerra as one of the founding members, has enjoyed a significant uptake of its proprietary drug class called Anticalin\u00ae on an international scale. The Company\u2019s Chief Executive Officer Stephen S. Yoder, who took the helm in 2010, shared his thoughts on the most recent developments with us."}